Patents Assigned to Apoxis SA
  • BAFF receptor (BCMA), an immunoregulatory agent
    Patent number: 7691804
    Abstract: A novel receptor in the TNF family is provided: BAFF-R. Chimeric molecules and antibodies to BAFF-R and methods of use thereof are also provided.
    Type: Grant
    Filed: February 15, 2002
    Date of Patent: April 6, 2010
    Assignees: Biogen Idec MA Inc., Apoxis SA
    Inventors: Browning Jeffrey, Ambrose Christine, MacKay Fabienne, Tschopp Jurg, Schneider Pascal, Thompson Jeffrey
  • Methods of treating a tumor that expresses APRIL by administering BCMA
    Patent number: 7276241
    Abstract: A novel receptor in the TNF family is provided: APRIL-R. Chimeric molecules and antibodies to APRIL-R and methods of use thereof are also provided.
    Type: Grant
    Filed: April 2, 2002
    Date of Patent: October 2, 2007
    Assignees: Biogen Idec MA Inc., Apoxis SA
    Inventors: Pascal Schneider, Jeffrey Thompson, Teresa Cachero, Christine Ambrose, Paul Rennert
  • Methods of treatment by administering an anti-BCMA antibody
    Patent number: 7083785
    Abstract: A novel receptor in the TNF family is provided: BAFF-R. Chimeric molecules and antibodies to BAFF-R and methods of use thereof are also provided.
    Type: Grant
    Filed: February 15, 2002
    Date of Patent: August 1, 2006
    Assignees: Biogen Idcc MA Inc., Apoxis SA
    Inventors: Jeffrey Browning, Christine Ambrose, Fabienne MacKay, Jurg Tschopp, Pascal Schneider, Jeffrey Thompson